Chemomab Therapeutics Ltd. American Depositary Share — Chart, Price & News (NASDAQ:CMMB) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Market Capitalization 12.1549 M
Employee 12
Founded 2011
CEO N/A
Website www.chemomab.com
Headquarter Israel
FIGI BBG00N0PMGK1
Industry Technology

Total revenue

Net income

Basic earnings per share (Basic EPS)

Total debt

Free cash flow

Cash & equivalents

12.15 M Market capitalization

Nouvelles

Le nebokitug de Chemomab montre un potentiel modificateur de la maladie dans l’essai sur la CSP

Chemomab’s nebokitug shows disease-modifying potential in PSC trial

Chemomab reports positive 48-week data for PSC drug nebokitug

ALKS to Enter Sleep Disorder Market With $2.1B Avadel Acquisition

Best Momentum Stocks to Buy for Oct. 23

New Strong Buy Stocks for Oct. 23: MQ, GES and More

SNY's Efdoralprin Alfa Meets Key Endpoints in Rare Disease Study

Roche's Gazyva Secures FDA Nod for Label Expansion in Lupus Nephritis

NVO's Rybelsus Gets FDA Nod to Reduce Heart Risk in Diabetes Patients

ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up

NVO and LLY Stocks Slide as Trump Signals Price Cuts for GLP-1 Drugs

Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan